资讯
Senate Finance Committee Chair Ron Wyden (D-OR) is urging HHS to take a stronger stance on healthcare companies' cybersecurity practices as the healthcare system is still piecing together what ...
Merck and Kelun-Biotech revealed Phase 3 breast cancer data for the lead antibody-drug conjugate in their potentially $12 billion partnership. In a Phase 3 trial … ...
In early August, Teva hit a bump in producing the popular ADHD drug Adderall, as the company faced a backorder of the drug in 20 mg and 30 mg ...
'We strongly dissent': Women biotech execs pen letter to colleagues and politicians in Roe v. Wade aftermath ...
The next generation of Operation Warp Speed is coming soon, and this time it's going to take aim at rare diseases, Peter Marks, the director of the FDA's Center for ...
April 29, 2024 05:53 PM EDT Updated 06:48 PM ...
Sanofi's BD chief heads to Owkin as CBO; Roche relies on its bench for Thomas Schinecker’s diagnostics replacement ...
Adagio raised $750M+ for an antibody against future variants. It failed against Omicron ...
CVS Health is shutting down the clinical trials business that it launched just two years ago, part of an effort to focus on its core … ...
The FDA is hoping its latest solution will stave off the continued shortage of cisplatin, a key drug used in treating several types of cancer. Beginning ...
Tech, commerce-focused investor unveils $500M bet on healthcare ...
Former Spark exec to lead a gene therapy upstart of his own; Big Pharma marketing vet named CEO of Swiss biotech ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果